E-LIB Suche - Ergebnisse für: Derijks, L. J. J.

1

P909 Proactive therapeutic drug monitoring and pharmacogeno..:

Anjie, S ; Derijks, L J ; Volkers, A G...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1662-i1663 , 2024

Link: https://doi.org/10.1093/..

2

P451 Early infliximab trough levels in paediatric IBD patie..:

Bevers, N ; Aliu, A ; Wong, D...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i581-i582 , 2023

Link: https://doi.org/10.1093/..

3

P592 Effectiveness and safety of thioguanine in thiopurine-..:

Crouwel, F ; Bayoumy, A B ; Mulder, C J J...
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i529-i529 , 2022

Link: https://doi.org/10.1093/..

4

A value proposition for trough level-based anti-TNFα drug d..:

Scharnhorst, V. ; Schmitz, E.M.H. ; van de Kerkhof, D...
Clinica Chimica Acta. 489 (2019) - p. 89-95 , 2019

Link: https://doi.org/10.1016/..

5

Switching from infliximab innovator to biosimilar in patien..:

Schmitz, E. M. H. ; Boekema, P. J. ; Straathof, J. W. A....
Alimentary Pharmacology & Therapeutics. 47 (2017) 3 - p. 356-363 , 2017

Link: https://doi.org/10.1111/..

6

Therapeutic drug monitoring (TDM) as a tool in the switch f..:

Schmitz, E. M. H. ; Benoy - De Keuster, S. ; Meier, A. J. L....
Clinical Rheumatology. 36 (2017) 9 - p. 2129-2134 , 2017

Link: https://doi.org/10.1007/..

7

Risk factors for thiopurine‐induced myelosuppression and in..:

Broekman, M. M. T. J. ; Coenen, M. J. H. ; Wanten, G. J....
Alimentary Pharmacology & Therapeutics. 46 (2017) 10 - p. 953-963 , 2017

Link: https://doi.org/10.1111/..

8

The glutathione transferase Mu null genotype leads to lower..:

in collaboration with TOPIC Recruitment Team ; Broekman, M M T J ; Wong, D R...
The Pharmacogenomics Journal. 18 (2017) 1 - p. 160-166 , 2017

Link: https://doi.org/10.1038/..

9

Early prediction of thiopurine‐induced hepatotoxicity in in..:

Wong, D. R. ; Coenen, M. J. H. ; Derijks, L. J. J....
Alimentary Pharmacology & Therapeutics. 45 (2016) 3 - p. 391-402 , 2016

Link: https://doi.org/10.1111/..

10

OP006 Personalized thiopurine dosing based on TPMT genotypi..:

Coenen, M. ; van Marrewijk, C. ; Derijks, L....
Journal of Crohn's and Colitis. 8 (2014) - p. S4 , 2014

Link: https://doi.org/10.1016/..

11

Short-term variation in plasma mitotane levels confirms the..:

Kerkhofs, T M A ; Derijks, L J J ; Ettaieb, M H T...
European Journal of Endocrinology. 171 (2014) 6 - p. 677-683 , 2014

Link: https://doi.org/10.1530/..

12

DOP035 Early assessment of thiopurine metabolites predicts ..:

Wong, D. ; Coenen, M. ; Derijks, L....
Journal of Crohn's and Colitis. 8 (2014) - p. S31-S32 , 2014

Link: https://doi.org/10.1016/..

13

Multiple intravenous doses of paracetamol result in a predi..:

van Ganzewinkel, C ; Derijks, L ; Anand, KJS...
Acta Paediatrica. 103 (2014) 6 - p. 612-617 , 2014

Link: https://doi.org/10.1111/..

14

P343 TPMT genotyping before thiopurine treatment results in..:

Coenen, M.J. ; van Marrewijk, C.J. ; Derijks, L....
Journal of Crohn's and Colitis. 7 (2013) - p. S147 , 2013

Link: https://doi.org/10.1016/..

15

Absence of nodular regenerative hyperplasia after low-dose ..:

de Boer, N.K.H. ; Zondervan, P.E. ; Gilissen, L.P.L....
Digestive and Liver Disease. 40 (2008) 2 - p. 108-113 , 2008

Link: https://doi.org/10.1016/..